Viral Hepatitis
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2006; 12(42): 6786-6791
Published online Nov 14, 2006. doi: 10.3748/wjg.v12.i42.6786
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 The effects of IFN and ACE-I on the serum hyaluronic acid in the patients with refractory chronic hepatitis C. A: Hyaluronic acid level before and after the study; B: % of change in the hyaluronic acid level in each group. Control: untreated control group; ACE-I, IFN: ACE-I- and IFN-treated groups, respectively; IFN + ACE-I: combination treated group with ACE-I and IFN. The data represent the mean ± SD.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 The effect of IFN and ACE-I on the serum 7-S-collagen in the patients with refractory chronic hepatitis C. A: The 7-S-collagen level before and after the study; B: % of change in the 7-S-collagen level in each group. Control: untreated control group. ACE-I, IFN: ACE-I- and IFN-treated groups, respectively. IFN + ACE-I: combination treated group with ACE-I and IFN. The data represent the means ± SD.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 The effects of IFN and ACE-I on the serum P-III-P in the patients with refractory chronic hepatitis C. A: P-III-P level before and after the study; B: % of change in the P-III-P level in each group. Control: untreated control group. ACE-I, IFN: ACE-I- and IFN-treated group, respectively. IFN + ACE-I: combination treated group with ACE-I and IFN. The data represent the means ± SD.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 The effects of IFN and ACE-I on the serum ALT in the patients with refractory chronic hepatitis C. A: ALT level before and after the study; B: % of change in the ALT level in each group. Control: untreated control group. ACE-I, IFN: ACE-I- and IFN-treated groups, respectively. IFN + ACE-I: combination treated group with ACE-I and IFN. The data represent the means ± SD.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 The effects of IFN and ACE-I on the serum TGF-β in the patients with refractory chronic hepatitis C. A: TGF-β level before and after the study; B: % of change in the TGF-β level in each group. Control: untreated control group. ACE-I, IFN: ACE-I- and IFN-treated groups, respectively. IFN + ACE-I: combination treated group with ACE-I and IFN. The data represent the means ± SD.